Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: Enzymes coordinately expressed in human endometrium

Biology of Reproduction

Volumn 62, Issue 1, 2000, Pages 85-94

  Zhang, Jin ^a   Hampton, Anne L ^a   Nie, Guiying ^a   Salamonsen, Lois A ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A; MESSENGER RNA; PROGESTERONE;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033966536     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod62.1.85     Document Type: Article

References (44)

1. Salamonsen LA, Woolley DE. Matrix metalloproteinases and their tissue inhibitors in endometrial remodelling and menstruation. Reprod Med Rev 1996; 5:185-203.
2. Salamonsen LA. Current concepts of the mechanisms of menstruation: a normal process of tissue destruction. Trends Endocrinol Metab 1998; 9:305-309.
3. Marbaix E, Kokorine I, Moulin P, Donnez J, Eeckhout Y, Courtoy PJ. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci USA 1996; 93:9120-9125.
4. Zhang J, Nie G-Y, Wang J, Woolley DE, Salamonsen LA. Mast cell regulation of endometrial stromal cell matrix metalloproteinases: a mechanism underlying menstruation. Biol Reprod 1998; 59:693-703.
5. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4:199-250.
6. Corcoran ML, Hewitt RE, Kleiner DE, Stetler-Stevenson WG. MMP-2: expression, activation and inhibition. Enzyme Protein 1996; 49:7-19.
7. Matrisian LM. Matrix metalloproteinase gene expression. Ann N Y Acad Sci 1994; 732:42-50.
8. Schonbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 1998; 161:3340-3346.
9. Strongin AJ, Marmer BL, Grant GA, Goldberg GI. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation of TIMP-2. J Biol Chem 1993; 268:14033-14039.
10. Murphy G, Willenbrock F, Crabbe T, Ward R, Atkinson SJ, O'Connell J, Docherty A. Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci 1994; 732:31-41.
11. Sato H, Takino T, Kinoshita T, Imai K, Stetler Stevenson WG, Seiki M. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett 1996; 385:238-240.
12. Butler GS, Will H, Atkinson SJ, Murphy G. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur J Biochem 1997; 244:653-657.
13. Nagase H. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res 1998; 8:179-186.
14. Lee AY, Akers KT, Collier M, Li L, Eisen AZ, Seltzer JL. Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc Natl Acad Sci USA 1997; 94:4424-4429.
15. Rodgers WH, Matrisian LM, Guidice LC, Dsupin B, Cannon P, Sviter C, Gorstein F, Osteen KG. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994; 94:946-953.
16. Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE, Salamonsen LA. Matrix metalloproteinase secretion by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase A, gelatinase B and stromelysin 1. Differential regulation by interleukin-lot and tumor necrosis factor β. J Clin Endocrinol Metab 1994; 79:530-536.
17. Irwin JC, Kirk D, Gwatkin RBL, Navre M, Cannon P, Guidice LC. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest 1996; 97:438-447.
18. Salamonsen LA, Butt AR, Hammond FR, Garcia S, Zhang J. Production of endometrial matrix metalloproteinases but not their tissue inhibitors is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 1997; 82:1409-1415.
19. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography - detection of picogram quantities of gelatinases. Anal Biochem 1994; 218: 325-329.
20. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
21. Walther W, Stein U, Eder C. RNA analysis using miniprep RNA in reverse transcription PCR. Biotechniques 1994; 17:674-675.
22. Nie G-Y, Wang J, Li Y, Salamonsen LA. Use of a multispecific competitor to quantify the gene expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in small human biopsies and small numbers of cultured cells. J Biochem Biophys Methods 1999; 40:81-99.
23. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1:3-25.
24. Hampton AL, Salamonsen LA. Endometrial expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors coincides with menstruation. J Endocrinol 1994; 141:R1-R3.
25. Borden P, Heller RA. Transcription control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryotic Gene Expr 1997; 7:159-178.
26. Migita T, Eguchi K, Kawabe Y, Ichinose Y, Tsukada T, Aoyagi T, Nakamura H. TNF-α-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 1996; 89:553-557.
27. Nawrocki B, Polette M, Marchand V, Maquoi E, Beorchia A, Tournier JM, Foidart JM, Birembaut P. Membrane-type matrix metalloproteinase-1 expression at the site of human placentation. Placenta 1995; 17: 565-572.
28. Tanaka SS, Togooka Y, Sato H, Seiki M, Tojo H, Tachi C. Expression and localization of membrane type matrix metalloproteinase-1 (MT1-MMP) in trophoblast cells of cultured mouse blastocysts and ectopla-cental cones. Placenta 1998; 19:41-48.
29. Singer CF, Marbaix E, Kokorine I, Lemoine P, Donnez J, Eeckhout Y, Courtoy PJ. Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin-1 α and its dual block by ovarian steroids. Proc Natl Acad Sci USA 1997; 94:10341-10345.
30. Zhang J, Salamonsen LA. Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle. Mol Hum Reprod 1997; 3:735-741.
31. Haas TL, Davis SJ, Madri JA. Three-dimensional type 1 collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 1998; 273:3604-3610.
32. Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WH, Jesty J. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. lnt J Cancer 1998; 75:780-786.
33. Galis ZS, Kranzhofer R, Fenton JW2, Libby P. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler Thromb Vase Biol 1997; 17:483-489.
34. McLaughlin B, Weiss JB. Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis. Biochem J 1996; 317:739-745.
35. Lijnen HR, Silence J, Lemmens G, Frederix L, Collen D. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thromb Haemostasis 1998; 79: 1171-1176.
36. Leung PHY, Salamonsen LA, Findlay JK. Immunolocalisation of inhibin and activin subunits in human endometrium across the menstrual cycle. Hum Reprod 1998; 13:3469-3477.
37. Vincent AJ, Malakooti N, Rogers PAW, Affandi B, Salamonsen LA. Endometrial breakdown in women using Norplant is associated with migratory cell expression of matrix metalloproteinase-9 (gelatinase B). Hum Reprod 1999; 14:807-815.
38. Salamonsen LA, Woolley DE. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol 1999; 44: 1-27.
39. Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995; 270:23013-23020.
40. Aplin JD. Cellular biochemistry of the endometrium. In: Wynn RM, Jollie WP (eds.), Biology of the Uterus. New York: Plenum Press; 1989: 89-129.
41. Jeziorska M, Nagase H, Salamonsen LA, Woolley DE. Immunolocalization of the matrix metalloproteinases, gelatinase B and stromelysin-1 in human endometrium throughout the menstrual cycle. J Reprod Fertil 1996: 107:43-51.
42. d'Ortho MP, Will H, Atkinson SJ, Butler GS, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 1997; 250:751-757.
43. Gillies C, Thompson EW. The epithelial to mesenchyma transition and metastatic progression in carcinoma. The Breast J 1996; 2:83-96.
44. Denker H-W. Cell biology of endometrial receptivity and of trophoblast-endometrial interactions. In: Glasser SR, Mulholland J, Psychoyos A (eds.), Endocrinology of Embryo-Endometrium Interactions. New York: Plenum Press; 1994: 17-32.